We are live on
!
Find out more
RA
Rise Advisors Portfolio holdings
AUM
$355M
1-Year Est. Return
20.51%
This Fund
S&P 500
This Quarter
Est. Return
-1.6%
1 Year Est. Return
+20.51%
3 Year Est. Return
+58.86%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$226M
AUM Growth
+$18.4M
(+8.9%)
Cap. Flow
+$24.3M
Cap. Flow
% of AUM
10.75%
Top 10 Holdings %
Top 10 Hldgs %
63.93%
Holding
1,580
New
463
Increased
381
Reduced
582
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Growth ETF
VUG
|
+$5.24M |
| 2 |
Vanguard Value ETF
VTV
|
+$4.36M |
| 3 |
FT Vest Laddered Moderate Buffer ETF
BUFZ
|
+$4.21M |
| 4 |
Dimensional US Targeted Value ETF
DFAT
|
+$3.64M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$3.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
|
+$3.74M |
| 2 |
PayPal
PYPL
|
+$3.04M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$572K |
| 4 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$203K |
| 5 |
Janus Henderson AAA CLO ETF
JAAA
|
+$178K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.6% |
| 2 | Financials | 5.8% |
| 3 | Consumer Discretionary | 3.39% |
| 4 | Healthcare | 3% |
| 5 | Industrials | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Q2 Holdings
QTWO
$3.79B
| $11.1K | ﹤0.01% |
+139
| New | +$12.3K |
|
902
Donaldson
DCI
$10.8B
| $11.1K | ﹤0.01% |
165
-121
| -42% | -$8.37K |
|
903
American States Water
AWR
$3.47B
| $11K | ﹤0.01% |
+140
| New | +$10.5K |
|
904
Quest Diagnostics
DGX
$26.2B
| $11K | ﹤0.01% |
+65
| New | +$10.7K |
|
905
Northern Trust
NTRS
$22.1B
| $10.9K | ﹤0.01% |
+111
| New | +$11.8K |
|
906
Littelfuse
LFUS
$10.6B
| $10.9K | ﹤0.01% |
56
-68
| -55% | -$15.6K |
|
907
Albemarle
ALB
$13.4B
| $10.9K | ﹤0.01% |
152
+41
| +37% | +$3.34K |
|
908
Atlanta Braves Holdings Series B
BATRK
$3.25B
| $10.9K | ﹤0.01% |
+273
| New | +$10.7K |
|
909
Prestige Consumer Healthcare
PBH
$2.44B
| $10.9K | ﹤0.01% |
127
-28
| -18% | -$2.3K |
|
910
Grand Canyon Education
LOPE
$4.15B
| $10.9K | ﹤0.01% |
63
-37
| -37% | -$6.42K |
|
911
Akamai
AKAM
$15.9B
| $10.9K | ﹤0.01% |
135
+11
| +9% | +$987 |
|
912
First Industrial Realty Trust
FR
$8.58B
| $10.9K | ﹤0.01% |
201
-162
| -45% | -$8.76K |
|
913
Lumentum
LITE
$48.5B
| $10.8K | ﹤0.01% |
174
-115
| -40% | -$8.85K |
|
914
Protagonist Therapeutics
PTGX
$8.71B
| $10.8K | ﹤0.01% |
+224
| New | +$9.39K |
|
915
Incyte
INCY
$25.6B
| $10.8K | ﹤0.01% |
178
-132
| -43% | -$9.21K |
|
916
Kilroy Realty
KRC
$4.62B
| $10.8K | ﹤0.01% |
329
-158
| -32% | -$5.66K |
|
|
THS
917
DELISTED
Treehouse Foods
THS
| $10.8K | ﹤0.01% |
397
+49
| +14% | +$1.55K |
|
918
SPS Commerce
SPSC
$2.56B
| $10.8K | ﹤0.01% |
81
| – | – |
|
919
Wendy's
WEN
$1.46B
| $10.7K | ﹤0.01% |
734
-201
| -21% | -$3.02K |
|
920
Moderna
MRNA
$21.8B
| $10.7K | ﹤0.01% |
378
+73
| +24% | +$2.59K |
|
921
Neogen
NEOG
$2B
| $10.7K | ﹤0.01% |
1,233
+157
| +15% | +$1.65K |
|
922
BridgeBio Pharma
BBIO
$16.6B
| $10.7K | ﹤0.01% |
+309
| New | +$10.4K |
|
923
ADMA Biologics
ADMA
$1.99B
| $10.7K | ﹤0.01% |
+538
| New | +$9.3K |
|
924
Globe Life
GL
$13.9B
| $10.7K | ﹤0.01% |
+81
| New | +$9.91K |
|
925
Equity Residential
EQR
$25.6B
| $10.7K | ﹤0.01% |
+149
| New | +$10.5K |
|
Similar funds
WKWM
WPC
CYG
SWM
PWAC
SFP
HC
AWP
Rise Advisors's Q1 2025 Portfolio in Review
As of Q1 2025, Rise Advisors held 1,580 positions worth $226M, up 8.9% from $208M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Rise Advisors deployed $24.3M of net new capital in Q1 2025, opening 463 new positions and adding to 381 existing holdings. Its largest new stake was FT Vest Laddered Moderate Buffer ETF: 175,274 shares worth $4.12M.
By sector, the portfolio is most concentrated in Technology at 7.6% of assets, up from 7.1% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was PayPal, an estimated $3.04M trimmed.
- Rise Advisors's largest Q1 2025 buy was FT Vest Laddered Moderate Buffer ETF: 175,274 shares worth $4.12M.
- Rise Advisors added most to Vanguard Growth ETF in Q1 2025, an estimated $5.24M increase.
- Rise Advisors's biggest Q1 2025 reduction was PayPal, cutting an estimated $3.04M.
- Rise Advisors fully exited WisdomTree Emerging Markets ex-State-Owned Enterprises Fund in Q1 2025, selling an estimated $3.74M.
- Rise Advisors's ten largest holdings make up 64% of its $226M portfolio in Q1 2025.
- Rise Advisors opened 463 new positions and closed 80 in Q1 2025.
- Rise Advisors's portfolio value rose 8.9% quarter-over-quarter to $226M.
Based on Rise Advisors's 13F filing for Q1 2025, filed 15 May 2025.